The relationship between microbial factors and gingival crevicular fluid glycosaminoglycans in human adult periodontitis.
Counts of cultivable Porphyromonas gingivalis, assays of microbial proteases and the concentration in gingival crevicular fluid of proteoglycan metabolites were investigated at periodontitis and gingivitis sites in 16 patients with chronic adult periodontitis before and after treatment. Two periodontitis sites and two gingivitis sites were selected from each patient on the basis of a clinical examination. Gingival crevicular fluid from each site was analysed for the concentrations of the glycosaminoglycans chondroitin-4-sulphate and hyaluronan and subgingival plaque samples were analysed for cultivable P. gingivalis and microbial trypsin-like proteases assayed by benzoyl-DL-arginine-naphthylamide (BANA) hydrolysis. Significantly higher concentrations (p = 0.007) of chondroitin-4-sulphate were found at periodontitis than gingivitis sites but there was no significant difference in hyaluronan (p = 0.36) between these sites. Although the majority of periodontal sites were P. gingivalis-negative (23/32), there were significantly higher concentrations of chondroitin-4-sulphate (p = 0.05) and hyaluronan (p = 0.04) at the P. gingivalis-positive, compared to negative, periodontitis sites. At BANA-positive periodontitis sites there were also higher concentrations of chondroitin-4-sulphate (p = 0.0015) and hyaluronan (p = 0.0001) than at BANA-positive gingivitis sites. There was a significant decrease in concentrations of chondroitin-4-sulphate and hyaluronan at periodontitis sites after treatment. This study lends support to the hypothesis that P. gingivalis may be actively involved in the destruction of connective tissue components at culture-positive sites but shows that elevated concentrations of connective tissue breakdown products may occur in gingival crevicular fluid from periodontal sites where this organism is absent.
Smith
A J
AJ
Oral Sciences Unit, Glasgow Dental School, U.K.
Wade
W
W
Addy
M
M
Embery
G
G
D000328:Adult; D001587:Benzoylarginine-2-Naphthylamide; D002809:Chondroitin Sulfates / Q000032:analysis; D002908:Chronic Disease; D015169:Colony Count, Microbial; D003773:Dental Plaque / Q000382:microbiology; D010450:Endopeptidases / Q000032:analysis; D005883:Gingival Crevicular Fluid / Q000737:chemistry / Q000201:enzymology; D005891:Gingivitis / Q000378:metabolism / Q000382:microbiology; D006025:Glycosaminoglycans / Q000032:analysis*; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis; D010518:Periodontitis / Q000378:metabolism* / Q000382:microbiology*; D016966:Porphyromonas gingivalis / Q000201:enzymology / Q000302:isolation & purification / Q000472:pathogenicity*
D006025:Glycosaminoglycans; D001587:Benzoylarginine-2-Naphthylamide; D006820:Hyaluronic Acid; D002809:Chondroitin Sulfates; D010450:Endopeptidases